Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database
ConclusionsThe most frequently reported suspected ADRs of asthma biologics in VigiBase confirmed the presence of well-known adverse effects such as general disorders, injection-site reactions, nasopharyngitis, headache and hypersensitivity, while some others (e.g. asthma reactivation or therapeutic failure) could be ascribed to the indication of use. Moreover, the analysis of signals of disproportionate reporting suggests the presence of malignancies, effects on the cardiovascular system, alopecia and autoimmune conditions, requiring further assessment and investigation.
Source: BioDrugs - Category: Drugs & Pharmacology Source Type: research
More News: Alopecia | Asthma | Cancer & Oncology | Cardiology | Cardiovascular | Common Cold | Corticosteroid Therapy | Cough | Databases & Libraries | Drugs & Pharmacology | Headache | Heart | Herpes | International Medicine & Public Health | Lichen Planus | Migraine | Pulmonary Thromboembolism | Study | Thrombosis | WHO | Women | Xolair